An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease
about
Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6AThe Modulation of Apoptotic Pathways by GammaherpesvirusesRecent advances in understanding Kaposi's sarcoma-associated herpesvirusCo-infections and Pathogenesis of KSHV-Associated MalignanciesIdentification of Human Herpesvirus 8 Sequences in Conjunctiva Intraepithelial Neoplasia and Squamous Cell Carcinoma of Ugandan PatientsKSHV: pathways to tumorigenesis and persistent infectionKSHV Entry and Trafficking in Target Cells-Hijacking of Cell Signal Pathways, Actin and Membrane DynamicsAnimal models of tumorigenic herpesviruses--an updateClinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana.Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.How do viruses trick B cells into becoming lymphomas?Coinfection with human herpesvirus 8 is associated with persistent inflammation and immune activation in virologically suppressed HIV-infected patients.Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.Contribution of viral mimics of cellular genes to KSHV infection and disease.KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis.Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseKSHV LANA--the master regulator of KSHV latency.Molecular biology of KSHV lytic reactivation.Evaluation of non-invasive multispectral imaging as a tool for measuring the effect of systemic therapy in Kaposi sarcomaHigh-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteomeA critical role for SOCS3 in innate resistance to Toxoplasma gondii.Systemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivoViral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.Episodic fevers and vasodilatory shock mimicking urosepsis in a patient with HIV-associated multicentric Castleman's Disease: a case report.A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South AfricaClinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational StudyPhase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.Virus-Mediated Alterations in miRNA Factors and Degradation of Viral miRNAs by MCPIP1.Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical traumaWhole-Genome Sequencing of Kaposi's Sarcoma-Associated Herpesvirus from Zambian Kaposi's Sarcoma Biopsy Specimens Reveals Unique Viral Diversity.Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling.Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation.
P2860
Q24607716-89321A8A-434E-42EF-B696-D613F551168CQ26747452-8CCE51D1-72F4-491E-97DB-23755F304B99Q26751238-1C40D1ED-7326-4302-8C35-4F520EBE95CFQ26766493-D089EC9D-A824-4D4C-ACEA-B11B4C2AE4BEQ26778220-02C5404A-6944-476F-A014-FAD4E1203E09Q27026000-AC5DC5A6-7798-4968-ACEC-024D4C43B375Q28072153-DC5852A6-5991-4BF7-AF58-FDBE293E6F00Q28083747-60C50356-4441-498F-990A-CA6A2A3EEB85Q33406437-C37A8205-34CD-49A4-B1C8-57A9240AC985Q33428328-AF8D5EC7-472C-465F-9416-96EC71A9F710Q33429461-97F37806-E3B5-4B21-84EB-C12C98301005Q33438403-F817052D-2B33-4E45-84A5-B625CEFE2CEDQ34020096-4A914F71-97EB-4BD3-9797-43333C6E4106Q34061952-99B7B0C5-0829-4EFA-B5DE-4357776D6113Q34168712-84EF2CD7-75CE-47F9-BD51-0268C2D294E9Q34303583-E10927ED-1CDC-4A5E-8B9E-8741E8479D72Q34417383-1BCF7EC7-2665-407F-85D1-2788E463D971Q34580878-167E35E3-AC2D-4256-8BF1-B872A8C9D561Q34636851-CA7F1EDA-1DE4-4C9D-A15E-9D30FB6A0FE4Q34774797-7C077D84-D034-466D-9D3E-BD4A0F10C3C4Q35014918-7922BC5F-CAC2-4397-BE88-A96187DA7892Q35080730-463ACF14-D3D6-4C7D-B001-2F4CB4569D82Q35127955-5E1D3BF2-E0E1-4022-880E-F51C5ACCB537Q35133590-6515865C-67E2-451C-8570-2A1E2485629CQ35222475-387415C8-C8DE-4485-9CFF-406A49A7158DQ35546590-9192A9E0-ABFC-42CD-8992-110584186B37Q35550033-07F33A49-88B3-4B10-B0DF-9956D0990637Q35795414-F1A0B0A1-8C4D-4879-A581-87EB755380E8Q35895560-CF46808B-212F-43D9-B28E-0DDAC53602A0Q35910542-700DDA25-7993-4A9D-90D0-0C00CDE1EB7EQ35989731-740223DC-DED2-4849-BAF4-77A48F830B88Q35991165-051B4093-4E8A-43D1-8BD4-B65AFA8431F7Q36058281-3D2C5A76-A9BA-48AA-A3DF-A1CB177A8E84Q36078761-81E2DACD-5637-46E7-9B6F-A0985E965C90Q36153930-1166985E-06AC-4481-9F71-0643F5D975A7Q36205470-07B37686-9C99-461D-B2C9-A87067752559Q36291986-F01C5031-5E7A-4C21-BC02-1AC821216195Q36334354-968E1EC6-4C04-4864-9ADD-6920B1B6B872Q36439695-29A34970-7840-44F9-A437-205951F11E14Q36483206-B520A30B-BF4B-45FE-80FA-C718FA0ABCAB
P2860
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An interleukin-6-related syste ...... Multicentric Castleman disease
@ast
An interleukin-6-related syste ...... Multicentric Castleman disease
@en
An interleukin-6-related syste ...... Multicentric Castleman disease
@nl
type
label
An interleukin-6-related syste ...... Multicentric Castleman disease
@ast
An interleukin-6-related syste ...... Multicentric Castleman disease
@en
An interleukin-6-related syste ...... Multicentric Castleman disease
@nl
prefLabel
An interleukin-6-related syste ...... Multicentric Castleman disease
@ast
An interleukin-6-related syste ...... Multicentric Castleman disease
@en
An interleukin-6-related syste ...... Multicentric Castleman disease
@nl
P2093
P2860
P356
P1476
An interleukin-6-related syste ...... Multicentric Castleman disease
@en
P2093
Deirdre O'Mahony
Denise Whitby
Giovanna Tosato
Irina Maric
Karen Aleman
Kathleen M Wyvill
Richard F Little
Robert Yarchoan
Seth M Steinberg
Stefania Pittaluga
P2860
P304
P356
10.1086/654798
P407
P577
2010-08-01T00:00:00Z